IRIS Accounts Production v24.2.0.383 10543665 director 30.9.22 29.9.23 29.9.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh105436652022-09-29105436652023-09-29105436652022-09-302023-09-29105436652021-09-30105436652021-10-012022-09-29105436652022-09-2910543665ns15:EnglandWales2022-09-302023-09-2910543665ns14:PoundSterling2022-09-302023-09-2910543665ns10:Director12022-09-302023-09-2910543665ns10:PrivateLimitedCompanyLtd2022-09-302023-09-2910543665ns10:Micro-entities2022-09-302023-09-2910543665ns10:AuditExempt-NoAccountantsReport2022-09-302023-09-2910543665ns10:FullAccounts2022-09-302023-09-2910543665ns5:CurrentFinancialInstruments2023-09-2910543665ns5:CurrentFinancialInstruments2022-09-2910543665ns5:Non-currentFinancialInstruments2023-09-2910543665ns5:Non-currentFinancialInstruments2022-09-2910543665ns10:RegisteredOffice2022-09-302023-09-29105436651ns10:Director12022-09-29105436651ns10:Director12021-09-30105436651ns10:Director12022-09-302023-09-29105436651ns10:Director12021-10-012022-09-29105436651ns10:Director12023-09-29105436651ns10:Director12022-09-29
REGISTERED NUMBER: 10543665 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 29 SEPTEMBER 2023

FOR

PENOVEX LIMITED

PENOVEX LIMITED (REGISTERED NUMBER: 10543665)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 SEPTEMBER 2023










Page

Balance Sheet 1


PENOVEX LIMITED (REGISTERED NUMBER: 10543665)

BALANCE SHEET
29 SEPTEMBER 2023

2023 2022
£ £ £ £
FIXED ASSETS 2,274 757

CURRENT ASSETS 61,469 13,103

CREDITORS
Amounts falling due within one year (36,159 ) (25,621 )
NET CURRENT ASSETS/(LIABILITIES) 25,310 (12,518 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

27,584

(11,761

)

CREDITORS
Amounts falling due after more than one
year

23,708

27,597
NET ASSETS/(LIABILITIES) 3,876 (39,358 )

CAPITAL AND RESERVES 3,876 (39,358 )

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Penovex Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10543665

Registered office: 71 Ellesmere Road
Berkhamsted
Hertfordshire
HP4 2ET

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2022 - 1 ) .

PENOVEX LIMITED (REGISTERED NUMBER: 10543665)

BALANCE SHEET - continued
29 SEPTEMBER 2023

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 29 September 2023 and the period ended 29 September 2022:

2023 2022
£ £
G Lishman
Balance outstanding at start of year - -
Amounts advanced 25,688 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 25,688 -

The loan is interest-free, unsecured and has no set repayment terms.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 September 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 13 September 2024 and were signed by:





G Lishman - Director